全文获取类型
收费全文 | 8124篇 |
免费 | 610篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 252篇 |
妇产科学 | 238篇 |
基础医学 | 1170篇 |
口腔科学 | 112篇 |
临床医学 | 851篇 |
内科学 | 1773篇 |
皮肤病学 | 111篇 |
神经病学 | 750篇 |
特种医学 | 192篇 |
外科学 | 915篇 |
综合类 | 135篇 |
一般理论 | 9篇 |
预防医学 | 822篇 |
眼科学 | 66篇 |
药学 | 523篇 |
中国医学 | 12篇 |
肿瘤学 | 685篇 |
出版年
2023年 | 71篇 |
2022年 | 102篇 |
2021年 | 200篇 |
2020年 | 116篇 |
2019年 | 212篇 |
2018年 | 248篇 |
2017年 | 157篇 |
2016年 | 178篇 |
2015年 | 212篇 |
2014年 | 270篇 |
2013年 | 399篇 |
2012年 | 574篇 |
2011年 | 574篇 |
2010年 | 314篇 |
2009年 | 249篇 |
2008年 | 416篇 |
2007年 | 423篇 |
2006年 | 405篇 |
2005年 | 359篇 |
2004年 | 336篇 |
2003年 | 308篇 |
2002年 | 300篇 |
2001年 | 176篇 |
2000年 | 174篇 |
1999年 | 155篇 |
1998年 | 75篇 |
1997年 | 53篇 |
1996年 | 54篇 |
1995年 | 52篇 |
1994年 | 60篇 |
1993年 | 42篇 |
1992年 | 117篇 |
1991年 | 122篇 |
1990年 | 94篇 |
1989年 | 101篇 |
1988年 | 103篇 |
1987年 | 93篇 |
1986年 | 93篇 |
1985年 | 75篇 |
1984年 | 51篇 |
1983年 | 48篇 |
1982年 | 34篇 |
1981年 | 30篇 |
1980年 | 32篇 |
1979年 | 66篇 |
1978年 | 50篇 |
1976年 | 34篇 |
1974年 | 32篇 |
1970年 | 26篇 |
1966年 | 26篇 |
排序方式: 共有8747条查询结果,搜索用时 10 毫秒
131.
132.
Pelargonio Gemma Di Monaco Antonio Guida Pietro Pellegrino Pier Luigi Vergara Pasquale Grimaldi Massimo Narducci Maria Lucia Tritto Massimo 《Journal of interventional cardiac electrophysiology》2022,63(1):125-132
Journal of Interventional Cardiac Electrophysiology - Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population. Catheter ablation... 相似文献
133.
Francesco Solimene MD Mario Giannotti Santoro MD Antonio De Simone MD Maurizio Malacrida MSc Giuseppe Stabile MD Claudio Pandozi MD Gemma Pelargonio PhD MD Filippo Maria Cauti MD Marco Scaglione MD Domenico Pecora MD Maria Grazia Bongiorni MD Alberto Arestia MD Gabriella Grimaldi MD Maurizio Russo MD Maria Lucia Narducci PhD MD Luca Segreti MD 《Journal of cardiovascular electrophysiology》2021,32(6):1540-1548
134.
135.
Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis 总被引:1,自引:0,他引:1
The pathogenesis of acute cholecystitis (AC) is controversial. Bile acids may be involved in the pathogenesis of AC because the hydrophobic chenodeoxycholic acid (CDCA) reproduced in vitro the muscle dysfunction observed in AC and was prevented by the hydrophilic ursodeoxycholic acid (UDCA). The present study examined the in vivo effects of UDCA or CDCA on gallbladder muscle dysfunction caused by AC. Guinea pigs were treated with placebo, UDCA, or CDCA for 2 weeks before sham operation or induction of AC by bile duct ligation (BDL) for 3 days. Pretreatment with oral UDCA prevented the defective contraction in response to agonists (acetylcholine [ACh], cholecystokinin 8 [CCK-8], and KCl) that occurs after BDL. Prostaglandin (PG) E(2)-induced contraction remained normal in the placebo and UDCA-treated groups but was impaired in the CDCA-treated group. Treatment with UDCA also prevented the expected increase in the levels of H(2)O(2), lipid peroxidation, and PGE(2) content in the placebo-treated AC group, whereas CDCA caused further increases in these oxidative stress markers. The binding capacity of PGE(2) to its receptors and the activity of catalase were reduced after treatment with CDCA. Treatment with UDCA enriched gallbladder bile acids with its conjugates and reduced the percentage of CDCA conjugates. In contrast, treatment with CDCA significantly decreased the percentage of UDCA in bile. In conclusion, oral treatment with UDCA prevents gallbladder muscle damage caused by BDL, whereas oral treatment with CDCA worsens the defective muscle contractility and the oxidative stress. 相似文献
136.
The present study was designed to determine the capability of human renal proximal tubule (RPT) to generate and export guanosine cyclic 3', 5' monophosphate (cGMP) in response to direct stimulation of soluble guanylyl cyclase by nitric oxide (NO) donors. In addition, we investigated whether cGMP extrusion from human RPT cells is required for inhibition of cellular sodium uptake. RPT cells were cultured from fresh human kidneys (normotensive subjects, n=4, mean age 65+/-4.7 years, 3 men, 1 woman; hypertensive patients, n=6, mean age 64+/-6.1 years, 4 men, 2 women) after unilateral nephrectomy. The fluorescence dye Sodium Green was employed to determine cytoplasmic Na+ concentration. In the presence of the Na+/K+ ATPase inhibitor ouabain, fluorescence was monitored at the appropriate wavelength (excitation 485 nm, emission 535 nm). Nitric oxide donor, S-nitroso-N-acetylpenicillamine (SNAP, 10(-4) M), increased both intracellular and extracellular cGMP (from 1.26+/-0.21 to 88.7+/-12.6 pmol/mg protein and from 0.58+/-0.10 to 9.24+/-1.9 pmol/mL, respectively, P<0.01) and decreased cellular Na+ uptake by 37.4+/-6.8% (P<0.05) compared with control. The effects of SNAP on cGMP production were similar in normotensive and hypertensive subjects. The increases in intracellular and extracellular cGMP concentration because of SNAP were blocked completely by soluble guanylyl cyclase inhibitor ODQ (1-H-[1,2,4] oxadiazolo [4,2-alpha] quinoxalin-1-one). Probenecid, an organic anion transport inhibitor, augmented the SNAP (10(-6) M)-induced increase in intracellular cGMP accumulation (from 4.9+/-0.9 to 9.8+/-1.5 pmol/mg protein, P<0.05), abrogated the SNAP-induced increase in extracellular cGMP extrusion (from 1.07+/-0.4 to 0.37+/-0.1 pmol/L, P<0.05) and blocked the SNAP-induced reduction in cellular Na+ uptake. Neither intracellular nor extracellular cGMP were influenced by l-arginine, the metabolic precursor of NO, or N(G)-nitro-L-arginine methyl ester, an inhibitor of NO synthase. After exogenous administration of cGMP (10(-5) M) or its membrane-permeable analogue 8-Br-cGMP (10(-5) M), only 8-Br-cGMP crossed the cell membrane to increase intracellular cGMP (from 1.36+/-0.19 to 289.7+/-29.4 pmol/mg protein, P<0.01). However, both cGMP and 8-Br-cGMP were effective in decreasing cellular Na+ uptake. In conclusion, human RPT cells contain soluble guanylyl cyclase and are able to generate and export cGMP in response to NO. Because human RPT cells do not themselves contain constitutive NO synthase, the NO-generating cGMP must be derived from sources outside the human RPT. The cGMP cellular export system is critical in the regulation of RPT cellular Na+ absorption in humans. 相似文献
137.
Jean-Paul Achkar M.D. Anthony B. Post M.D. Edgar Achkar M.D. William D. Carey M.D. 《The American journal of gastroenterology》1995,90(1):39-43
Objectives : It has been suggested that the presence of Barrett's mucosa is a marker for potential malignancy in other organs. Our objective was to study subjects with adenocarcinoma of the esophagus arising in Barrett's epithelium. Methods : We reviewed the medical records of patients with esophageal adenocarcinoma, with esophageal squamous cell carcinoma, and with no esophageal pathology and recorded the occurrence of extrae-sophageal malignancies and the heavy use of tobacco and alcohol. Results : The prevalence of extraesophageal malignancies was not higher in patients with esophageal adenocarcinoma (15%) than in patients in either control group (14% each). Patients with either type of cancer of the esophagus had higher rates of tobacco and alcohol use than normal controls (tobacco: p = 0.02 and/7 < 0.01 for adenocarcinoma and squamous cell carcinoma, respectively, vs. normal controls; alcohol:/; < 0.01 for each esophageal malignancy vs . normal controls). The rate of tobacco and alcohol use was higher in patients with esophageal squamous cell carcinoma than in those with adenocarcinoma, but only the difference in alcohol consumption was statistically significant ( p < 0.01). Conclusion : Patients with adenocarcinoma of the esophagus are not at higher risk for development of extraesophageal malignancy. This observation applies to both those with and without underlying Barrett's epithelium. Alcohol and tobacco use appear to be related to the malignant transformation of esophageal epithelium. 相似文献
138.
C.Alan Brown Clive L. Hall John C. Long Kathleen Carey Sigmund A. Weitzman Alan C. Aisenberg 《The American journal of medicine》1978,64(2):289-294
Levels of circulating immune complexes (CIC) in the serum of patients with Hodgkin's disease were measured by the Raji cell radioimmunoassay. Elevated levels of immune complexes (mean value of 49 μg/ml ± 21 SE) were detected in 20 of 40 (50 per cent) untreated patients. After treatment, the level of CIC was normal (< 15 μg/ml) in 39 of 41 patients. Recurrent disease developed in two of the 39 patients with normal post-treatment levels of CIC and in one of the two patients with elevated post-treatment levels during the follow-up period of six months to six years. Elevated levels of CIC were detected in patients with Hodgkin's disease in stages I, II and III but not in stage IV. No significant correlations were found in the frequency of elevated levels of CIC or the values observed, and the presence or absence of symptoms (fever, sweats, weight loss) or the histologic subtype of the tumor. Our data indicate that the measurement of CIC by the sensitive and specific Raji cell assay may prove useful in the management of patients with Hodgkin's disease. In particular, serial measurement of the level of CIC could be employed to monitor the response to treatment and to detect recurrent diseases. 相似文献
139.
Carey EC Covinsky KE Lui LY Eng C Sands LP Walter LC 《Journal of the American Geriatrics Society》2008,56(1):68-75
OBJECTIVES: To develop and validate a prognostic index for mortality in community‐living, frail elderly people. DESIGN: Cohort study of Program of All‐Inclusive Care for the Elderly (PACE) participants enrolled between 1988 and 1996. SETTING: Eleven PACE sites, a community‐based long‐term care program that cares for frail, chronically ill elderly people who meet criteria for nursing home placement. PARTICIPANTS: Three thousand eight hundred ninety‐nine PACE enrollees. The index was developed in 2,232 participants and validated in 1,667. MEASUREMENTS: Time to death was predicted using risk factors obtained from a geriatric assessment performed by the PACE interdisciplinary team at the time of enrollment. Risk factors included demographic characteristics, comorbid conditions, and functional status. RESULTS: The development cohort had a mean age of 79 (68% female, 40% white). The validation cohort had a mean age of 79 (76% female, 65% white). In the development cohort, eight independent risk factors of mortality were identified and weighted, using Cox regression, to create a risk score: male sex, 2 points; age (75–79, 2 points; 80–84, 2 points; ≥85, 3 points); dependence in toileting, 1 point; dependence in dressing (partial dependence, 1 point; full dependence, 3 points); malignant neoplasm, 2 points; congestive heart failure, 3 points; chronic obstructive pulmonary disease, 1 point; and renal insufficiency, 3 points. In the development cohort, respective 1‐ and 3‐year mortality rates were 6% and 21% in the lowest‐risk group (0–3 points), 12% and 36% in the middle‐risk group (4–5 points), and 21% and 54% in the highest‐risk group (>5 points). In the validation cohort, respective 1‐ and 3‐year mortality rates were 7% and 18% in the lowest‐risk group, 11% and 36% in the middle‐risk group, and 22% and 55% in the highest‐risk group. The area under the receiver operating characteristic curve for the point score was 0.66 and 0.69 in the development and validation cohorts, respectively. CONCLUSION: A multidimensional prognostic index was developed and validated using age, sex, functional status, and comorbidities that effectively stratifies frail, community‐living elderly people into groups at varying risk of mortality. 相似文献
140.
S M Herf D C Teates C J Tegtmeyer E D Vaughan C R Ayers R M Carey 《The American journal of medicine》1979,67(3):397-402
During a protocol study for the evaluation of patients with primary aldosteronism, a variety of diagnostic studies were employed in an attempt to identify patients with primary aldosteronism and to differentiate patients with adrenal adenoma from patients with idiopathic adrenal hyperplasia. In this study, we are able to demonstrate the utility of (1) absent postural increase in plasma aldosterone concentration, (2) adrenal scanning and (3) normalization of blood pressure with spironolactone therapy in identifying patients with primary aldosterone excess who have an adrenal adenoma, surgical removal of which results in eliminating their hypertension. 相似文献